You are about to leave the Clinical Value website now.

Cancel

Liver Disease and Patient Advocacy in Taiwan: Q&A with Prof Yang Pei-Ming

You May Also Like

Cost Utility of Novel Biomarker Based Strategies for Hepatocellular Carcinoma HCC Surveillance in Thailand featured image
Health Economics
27 June 2024

Cost-Utility of Novel Biomarker-Based Strategies for Hepatocellular Carcinoma (HCC) Surveillance in Thailand

Read More

SHARE

Be the first to receive updates, event opportunities, and thought leadership insights.

The information contained in this website is intended for healthcare professionals only.
Click “OK” if you are a healthcare professional.

OK